Artiva Biotherapeutics ARTV
NASDAQ ARTV
$7.12 +0.09 (+1.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Asset Utilization Ratio (2024)

Updated

Artiva Biotherapeutics' (ARTV) Asset Utilization Ratio stood at 0.00 in Q4 2024, down 93.3% from the prior quarter.

Analysis

Artiva Biotherapeutics (ARTV) Asset Utilization Ratio (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 Artiva Biotherapeutics 280.62 Mn 280.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 0.00
Sep 30, 2024 0.02
API Access

Artiva Biotherapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ARTV&period=max&api_key=YOUR_API_KEY